In another scientific seminar at Dhaka Club, Prof Guido Ferlazzo presented on the Role of Bacterial Lysates in the prophylaxis of RTIs. In view of the additional mechanisms of actions identified for Ismigen (i.e. local reinforcement of mucosal innate barriers), the modality of administration (sublingual for dissolving in oropharyngeal district) offers an obvious unique advantage. Improving these innate barriers at the main gate of entry for pathogens involved in respiratory infections (oro-pharynx), strongly suggest an indication of Ismigen for several infective pathologies including rhinosinusitis, pharyngitis, tonsillitis, otitis.
Prof Mustafizur Rahman, President, Bangladesh Society of Allergy and Immunology, Prof. Mirza Mohammad Hiron, President, Chest and Heart Association of Bangladesh, Prof Kamrul Hassan Tarafder, President, Bangladesh Society of Otolaryngologists and Head Neck Surgeons, Prof. Rashidul Hassan, President, Bangladesh Lung Foundation, Prof Khan Abul Kalam Azad, Former President, Bangladesh Society of Medicine and Principal, Dhaka Medical College, Prof. Md. Ali Hossain, Secretary General, Bangladesh Lung Foundation was present as panel members in this scientific seminar and they thanked UniMed UniHealth Pharmaceuticals for launching this product in Bangladesh market, they remarked, it will reduce the cost and help the huge number of COPD patients in Bangladesh.
In welcome address Mr. Mossadek Hossain, Managing Director, UniMed UniHealth Pharmaceuticals mentioned about the partnership with the Lallemand Pharma and he thanked Lallemand Pharma for this opportunities to introduce ISMIGEN in Bangladesh. He also stated that ISMIGEN® tablets are being manufactured in their plant in Bangladesh. UniMed UniHealth will be initially focusing the prophylaxis approach for recurrent infections of the upper respiratory tract and the prevention of acute exacerbation of COPD patients.